58.94
Real-Time Quote
 -0.62 / -1.04%
Today’s Change
47.53
Today|||52-Week Range
61.15
+15.57%
Year-to-Date
Healthcare M&A activity hits record level
12:43pm / Fortune
5 Stories You Can't Miss About Big Pharma, Facebook: StockTwits
Apr 22 / TheStreet.com
This Big Pharma Just Went to the Dogs, and That's Great News for Shareholders
12:03pm / MotleyFool.com
Alexion Likely to Keep Earnings Streak Alive - Analyst Blog
Apr 22 / Zacks.com
Should You Buy Eli Lilly (LLY) Ahead of Earnings? - Tale of the Tape
9:11am / Zacks.com
Eli Lilly: momentum and mean reversion
Apr 22 / FT.com
Earnings Scheduled For April 24, 2014
6:58am / Benzinga
Stocks Flirt With All-Time Highs on Earnings, Deals News
Apr 22 / TheStreet.com
Novartis Signs Deals With GlaxoSmithKline & Eli Lilly - Analyst Blog
Apr 23 / Zacks.com
Today's Health Care Stocks to Watch: Eli Lilly and Co, GlaxoSmithKline plc, Novartis ...
Apr 22 / MotleyFool.com
Market Wrap For April 23: S&P 500 Ends Winning Streak, Apple Announces 7-for-1 Stock ...
Apr 23 / Benzinga
US Stock Futures Edge Higher Ahead Of McDonald's Earnings
Apr 22 / Benzinga
Will Eli Lilly (LLY) Keep Its Earnings Streak Alive? - Analyst Blog
Apr 23 / Zacks.com
Why GlaxoSmithKline (GSK) Stock Is Higher This Morning
Apr 22 / TheStreet.com
Novartis Signs Deals with Glaxo, Lilly - Analyst Blog
Apr 23 / Zacks.com
Market Hustle: Stock Futures in Wait-and-See Mode
Apr 22 / TheStreet.com
Will AmerisourceBergen (ABC) Beat Earnings Estimates? - Analyst Blog
Apr 23 / Zacks.com
European Stocks Rise, Led by Pharma Sector News
Apr 22 / TheStreet.com
Will Celgene (CELG) Miss this Earnings Season? - Analyst Blog
Apr 23 / Zacks.com
Will Amgen (AMGN) Miss This Earnings Season? - Analyst Blog
Apr 21 / Zacks.com
Stock Market News for April 23, 2014 - Market News
Apr 23 / Zacks.com
No Legwork Mondays b Takeda, Eli Lilly, And Actos
Apr 21 / Benzinga
Will Eli Lilly (LLY) Stock Be Hurt By This Downgrade?
Apr 23 / TheStreet.com
Will Gilead (GILD) Beat Q1 Earnings? - Analyst Blog
Apr 21 / Zacks.com
Analysts' Actions: AGN AOS COG ETFC LLY
Apr 23 / TheStreet.com
Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making?
Apr 21 / MotleyFool.com
Why Pentair, Zions Bancorp, and Eli Lilly & Co. Are Todaybs 3 Worst Stocks
Apr 22 / MotleyFool.com
The Biggest Biotech Wins of the Week
Apr 15 / MotleyFool.com
Benzinga's M&A Chatter for Tuesday April 22, 2014
Apr 22 / Benzinga
Eli Lilly/ Boehringer Drug Under FDA Review - Analyst Blog
Apr 15 / Zacks.com
Is Biogen (BIIB) Poised to Beat Earnings Estimates? - Analyst Blog
Apr 22 / Zacks.com
Eli Lilly's $3 Billion Mistake
Apr 14 / MotleyFool.com
Eli Lilly to Acquire Novartis' Animal Health Biz - Analyst Blog
Apr 22 / Zacks.com
MannKind's Overly-Optimisitic Investors
Apr 14 / MotleyFool.com
Eli Lilly And Company (LLY): Today's Featured Drugs Laggard
Apr 22 / TheStreet.com
Is Teva Pharmaceutical Industries Ltd. Destined for Greatness?
Apr 14 / MotleyFool.com
Deals fever grips pharmaceuticals industry
Apr 22 / FT.com
Can This Drug Be a Game Changer for Eli Lilly?
Apr 11 / MotleyFool.com
Is This a Good Deal for Novartis AG and GlaxoSmithKline plc?
Apr 22 / MotleyFool.com
2 Biotech Stocks to Watch: Merrimack Pharmaceuticals and Sunesis Pharmaceuticals
Apr 10 / MotleyFool.com
Eli Lilly: animal spirits
Apr 22 / FT.com
3 Stocks Near 52-Week Highs Worth Selling
Apr 10 / MotleyFool.com
3 Stocks Pushing The Health Care Sector Downward
Apr 22 / TheStreet.com
3 Breast Cancer Drugs With Big Potential
Apr 10 / MotleyFool.com
Tuesday Links: Bullish On Hedge Funds
Apr 22 / StockTwits
Takeda and Eli Lilly fall foul of jury in Actos trial
Apr 08 / FT.com
Novartis Reshapes Portfolio via GSK, Eli Lilly Deals
Apr 22 / TheStreet.com
Takeda: a fine mess
Apr 08 / FT.com
Notable Mergers and Acquisitions of the Day 04/22: (GSK)/(NVS) (VRX)/(AGN) (CDNS)
Apr 22 / Investing Channel
Takeda ordered to pay $6bn over diabetes drug claims
Apr 08 / FT.com

To view my watchlist

Not a member yet?

Sign up now for a free account
Market indexes are shown in real time, except for the DJIA, which is delayed by two minutes. All times are ET. Disclaimer LIBOR Warning: Neither BBA Enterprises Limited, nor the BBA LIBOR Contributor Banks, nor Reuters, can be held liable for any irregularity or inaccuracy of BBA LIBOR. Disclaimer. Morningstar: © 2014 Morningstar, Inc. All Rights Reserved. Disclaimer The Dow Jones IndexesSM are proprietary to and distributed by Dow Jones & Company, Inc. and have been licensed for use. All content of the Dow Jones IndexesSM © 2014 is proprietary to Dow Jones & Company, Inc. Chicago Mercantile Association. The market data is the property of Chicago Mercantile Exchange Inc. and its licensors. All rights reserved. FactSet Research Systems Inc. 2014. All rights reserved. Most stock quote data provided by BATS.